2026年3月最新《新锐期刊分区表》数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿｜IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | JOURNAL OF CLINICAL ONCOLOGY J CLIN ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.9
53人评分
我要评分
声誉 9.9 影响力 9.9 速度 9.1 | |||||||||||||||||||||
| 期刊ISSN | 0732-183X | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1527-7755 | |||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 43.4 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：42.85 | |||||||||||||||||||||
| 2024-2025自引率 | 1.8%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 38.2 | |||||||||||||||||||||
| JCI期刊引文指标 | 6.77 | |||||||||||||||||||||
| h-index | 494 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://jco.ascopubs.org/ | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/JCO-ASCOPUBS | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Radiosurgery for Small Cell Lung Cancer Brain Metastases: Comparing the JLGK0901 and BWH/DFCI Trials Author: Rusthoven, Chad G.; Serizawa, Toru; Yamamoto, Masaaki Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 12, pp. 1174-1175. DOI: 10.1200/JCO-25-01794 Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study Author: Licitra, Lisa; Tahara, Makoto; Harrington, Kevin; Olivera Hurtado de Mendoza, Mivael; Guo, Ye; Aksoy, Sercan; Fang, Meiyu; Csőszi, Tibor; Klochikhin, Mikhail; Bueno de Oliveira, Thiago; Takahashi, Shunji; Yang, Muh-Hwa; Swiecicki, Paul L.; Even, Caroline; Fayette, Jérome; Dutcus, Corina; Okpara, Chinyere E.; Shen, Juan; Benjamin, Kimberly; Gumuscu, Burak; Haddad, Robert I Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 12, pp. 1098-1107. DOI: 10.1200/JCO-25-00570 Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial Author: Zhu, Hai-Dong; Fan, Wei-Jun; Zhao, Chang; Wang, Song; Li, Yu-Liang; Jin, Zhi-Cheng; Zhang, Zhe-Wei; Guo, Jin-He; Cheng, Hong-Tao; Zhang, Qi; Lu, Jian; Zeng, Yong-Yi; Lv, Wei-Fu; Xu, Hao; Shao, Hai-Bo; Xu, Wei-Guo; Zhao, Xu-Ya; Gu, Shan-Zhi; Lin, Hai-Lan; Zheng, Wen-Heng; Piao, Long-Zhen; Song, Yu-Sheng; Zhao, Jian-Bo; Wang, Yuan-Cheng; Hou, Zhi-Guo; Sun, Ying; Guan, Ni; Huang, Ming; Yang, Wei-Zhu; Ji, Jian-Song; Teng, Gao-Jun Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 11, pp. 959-969. DOI: 10.1200/JCO-25-01796 Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001) Author: Yan, Wenqiang; Du, Chenxing; Lv, Rui; Zou, Hesong; Zhang, Shuaishuai; Yu, Tengteng; Yan, Yuting; Zhang, Yanlei; Peng, Shuixiu; Wang, Tingyu; Deng, Shuhui; Huang, Wenyang; Yi, Shuhua; Zou, Dehui; Cheng, Tao; Wang, Jianxiang; Chang, Alex H.; Qiu, Lugui; An, Gang Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 11, pp. 992-1002. DOI: 10.1200/JCO-25-01969 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足JOURNAL OF CLINICAL ONCOLOGY的语言要求，还能让JOURNAL OF CLINICAL ONCOLOGY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被JOURNAL OF CLINICAL ONCOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | AMER SOC CLINICAL ONCOLOGY, 2318 MILL ROAD, STE 800, ALEXANDRIA, USA, VA, 22314 | |||||||||||||||||||||
| 出版商 | American Society of Clinical Oncology | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Biweekly | |||||||||||||||||||||
| 出版年份 | 1983 | |||||||||||||||||||||
| 年文章数 | 365点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 24.89% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 93.70% | |||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0732-183X%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均2月 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约20% | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在JOURNAL OF CLINICAL ONCOLOGY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Radiosurgery for Small Cell Lung Cancer Brain Metastases: Comparing the JLGK0901 and BWH/DFCI Trials Author: Rusthoven, Chad G.; Serizawa, Toru; Yamamoto, Masaaki Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 12, pp. 1174-1175. DOI: 10.1200/JCO-25-01794 PubMed DOI |
| 2. | Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study Author: Licitra, Lisa; Tahara, Makoto; Harrington, Kevin; Olivera Hurtado de Mendoza, Mivael; Guo, Ye; Aksoy, Sercan; Fang, Meiyu; Csőszi, Tibor; Klochikhin, Mikhail; Bueno de Oliveira, Thiago; Takahashi, Shunji; Yang, Muh-Hwa; Swiecicki, Paul L.; Even, Caroline; Fayette, Jérome; Dutcus, Corina; Okpara, Chinyere E.; Shen, Juan; Benjamin, Kimberly; Gumuscu, Burak; Haddad, Robert I Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 12, pp. 1098-1107. DOI: 10.1200/JCO-25-00570 PubMed DOI |
| 3. | Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial Author: Zhu, Hai-Dong; Fan, Wei-Jun; Zhao, Chang; Wang, Song; Li, Yu-Liang; Jin, Zhi-Cheng; Zhang, Zhe-Wei; Guo, Jin-He; Cheng, Hong-Tao; Zhang, Qi; Lu, Jian; Zeng, Yong-Yi; Lv, Wei-Fu; Xu, Hao; Shao, Hai-Bo; Xu, Wei-Guo; Zhao, Xu-Ya; Gu, Shan-Zhi; Lin, Hai-Lan; Zheng, Wen-Heng; Piao, Long-Zhen; Song, Yu-Sheng; Zhao, Jian-Bo; Wang, Yuan-Cheng; Hou, Zhi-Guo; Sun, Ying; Guan, Ni; Huang, Ming; Yang, Wei-Zhu; Ji, Jian-Song; Teng, Gao-Jun Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 11, pp. 959-969. DOI: 10.1200/JCO-25-01796 PubMed DOI |
| 4. | Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001) Author: Yan, Wenqiang; Du, Chenxing; Lv, Rui; Zou, Hesong; Zhang, Shuaishuai; Yu, Tengteng; Yan, Yuting; Zhang, Yanlei; Peng, Shuixiu; Wang, Tingyu; Deng, Shuhui; Huang, Wenyang; Yi, Shuhua; Zou, Dehui; Cheng, Tao; Wang, Jianxiang; Chang, Alex H.; Qiu, Lugui; An, Gang Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 11, pp. 992-1002. DOI: 10.1200/JCO-25-01969 PubMed DOI |
| 5. | Reply to: Delta-Like Ligand 3 Expression Across Lung Neuroendocrine Subtypes: Interpreting Response in Small Cell Lung Cancer and Beyond Author: Wermke, Martin; Gambardella, Valentina; Kuboki, Yasutoshi; Felip, Enriqueta; Sanmamed, Miguel F.; Alese, Olatunji B.; Sayehli, Cyrus M.; Arriola, Edurne; Wolf, Jürgen; Villaruz, Liza C.; Bertulis, Julia; Studeny, Matus; Bouzaggou, Mohamed; Fang, Xiaoyan; Morgensztern, Daniel Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 11, pp. 1062-1064. DOI: 10.1200/JCO-25-02654 PubMed DOI |
| 6. | Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial Author: Mei, Wei-Jian; Wang, Xiao-Zhong; Zhang, Xuan; Sun, Yue-Ming; Yang, Chun-Kang; Lin, Jun-Zhong; Wu, Zu-Guang; Zhang, Rui; Wang, Wei; Li, Yong; Zhuang, Ye-Zhong; Lei, Jian; Wan, Xiang-Bin; Ren, Ying-Kun; Cheng, Yong; Li, Wen-Liang; Wang, Zi-Qiang; Xu, Dong-Bo; Mo, Xian-Wei; Ju, Hai-Xing; Ye, Sheng-Wei; Zhao, Jing-Lin; Zhang, Hong; Gao, Yuan-Hong; Zeng, Zhi-Fan; Xiao, Wei-Wei; Zhang, Xiao-Peng; Li, Yun-Feng; Xie, E; Feng, Yi-Fei; Tang, Jing-Hua; Wu, Xiao-Jun; Chen, Gong; Li, Li-Ren; Lu, Zhen-Hai; Wan, De-Sen; Bei, Jin-Xin; Pan, Zhi-Zhong; Yu, Jie-Hai; Ding, Pei-Rong Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 11, pp. 970-980. DOI: 10.1200/JCO-25-00731 PubMed DOI |
| 7. | Mifamurtide in Nonmetastatic High-Grade Osteosarcoma Author: Li, Huan-Ning Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 11, pp. 1060-1060. DOI: 10.1200/JCO-25-02154 PubMed DOI |
| 8. | Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials Author: Huang, Sai-Wei; Liang, Ye-Lin; Tao, Ya-Lan; Li, Wen-Fei; Zhou, Guan-Qun; Mao, Yan-Ping; Guo, Rui; Chen, Lei; Xu, Sha; Liu, Xu; Zhang, Ning; Liu, Fang; Shen, Liang-Fang; Zhou, Yang-Ying; Yuan, Ya-Wei; Zou, Guo-Rong; Jin, Feng; Tang, Ling-Long; Sun, Ying; Li, Ying-Qin; Ma, Jun; Liu, Na Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 11, pp. 1028-1039. DOI: 10.1200/JCO-25-02111 PubMed DOI |
| 9. | Delta-Like Ligand 3 Expression Across Lung Neuroendocrine Subtypes: Interpreting Response in Small Cell Lung Cancer and Beyond Author: Chen, Yitian; Liu, Li; Ming, Yang; Chen, Ligang Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 11, pp. 1061-1062. DOI: 10.1200/JCO-25-01894 PubMed DOI |
| 10. | Izalontamab Brengitecan in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations Outside of Classical EGFR Mutations: A Phase Ib Study Author: Zhou, Huaqiang; Zhao, Hongyun; Hou, Xue; Wang, Yongsheng; He, Zhiyong; Li, Yongsheng; Ma, Yuxiang; Zhao, Yuanyuan; Huang, Yan; Chen, Likun; Xiao, Sa; Zhu, Hai; Zhu, Yi; Fang, Wenfeng; Zhang, Li; Yang, Yunpeng Journal: JOURNAL OF CLINICAL ONCOLOGY. 2026; Vol. 44, Issue 10, pp. 893-902. DOI: 10.1200/JCO-25-01929 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共117条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
